HALISTER: Sanofi Said to Be in Talks to Buy Actelion: WSJ

Sanofi Said to Be in Talks to Buy Actelion: WSJ

(Bloomberg) -- Sanofi is in talks with Actelion for a deal which could value Actelion at as much as $30b, WSJ reports, citing unidentified people familiar.
  • Unclear what price Sanofi is discussing paying or what structure is envisioned: WSJ
  • NOTE: Earlier, Johnson & Johnson Says It Has Ended Deal Talks With Actelion
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
ATLN VX (Actelion Ltd)
SAN FP (Sanofi)
JNJ US (Johnson & Johnson)

To de-activate this alert, click here

UUID: 7947283